Atrial Fibrillation (AF) is a prevalent heart rhythm disorder characterized by irregular and often rapid heartbeats. In this condition, the heart's upper chambers (atria) quiver or flutter, disrupting the normal electrical impulses that coordinate heartbeats. As a result, the heart may not pump blood effectively, leading to potential complications such as blood clots, stroke, or heart failure. AF can affect individuals of any age, but it becomes more common with age, and certain factors such as hypertension, diabetes, and heart disease can elevate the risk. Symptoms may include palpitations, fatigue, dizziness, and shortness of breath. Timely diagnosis and management of Atrial Fibrillation are crucial to mitigate associated risks and enhance the quality of life for those affected. Treatment strategies often involve medications, lifestyle modifications, and in some cases, medical procedures to restore or regulate the heart's rhythm. As research continues to advance, a better understanding of the mechanisms behind AF and innovative treatment options offer hope for improved outcomes and enhanced patient care
Title : Pharmacological advancement in pulmonary arterial hypertension treatment - Contribution of treprostinil dry-powder formulation
Miroslav Radenkovic, University of Belgrade, Serbia